CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist
  • 31.74
  • -0.02-0.06%
Not Open Dec 5 15:00 CST
24.44BMarket Cap26.21P/E (TTM)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats

Tianjin Pharmaceutical Da Ren Tang Group Corporation Q3 2024 Earnings Date

Currency:CNYOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
1.65B
--
-3.43%
EPS
--
0.19
--
--
Strong Buy

Dec 5, 2024

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.544B--
--2024/FY-- / 8.725B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.544B--
--2024/FY-- / 8.725B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--

Unlock Free Earnings Estimates

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 5, 2024

Strong Buy

  • Strong Buy

    68.75%
  • Buy

    31.25%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data